TD Cowen Raises Price Target on Eli Lilly to $1,050 From $850
Sprouts Farmers Market Analyst Ratings
Goldman Sachs Adjusts Price Target on Eli Lilly to $812 From $793
Tenet Healthcare Analyst Ratings
Eli Lilly and Co Analyst Ratings
Eli Lilly & Co (LLY) Gets a Buy From Barclays
UBS Raises Price Target on Eli Lilly to $1,100 From $910, Maintains Buy Rating
Citigroup Adjusts Price Target on Amphenol to $81 From $80
Berenberg Maintains Buy on Eli Lilly and Co, Raises Price Target to $1000
TD Cowen Adjusts Price Target on United Therapeutics to $350 From $270, Maintains Buy Rating
Analysts Conflicted on These Technology Names: ServiceNow (NOW) and NetApp (NTAP)
Berenberg Adjusts Price Target on Eli Lilly & Co. to $1,000 From $850, Maintains Buy Rating
United Therapeutics Analyst Ratings
Eli Lilly and Co Analyst Ratings
Tenet Healthcare Analyst Ratings
Goldman Sachs Adjusts Price Target on Sprouts Farmers Market to $89 From $78, Maintains Buy Rating
Sprouts Farmers Market Analyst Ratings
Amphenol Analyst Ratings
Buy Rating Affirmed With Increased Price Target as Amphenol Expects Earnings Beat and Strong Growth
Barclays Sticks to Its Buy Rating for Tenet Healthcare (THC)